Eliem Therapeutics, Inc., a Redmond, WA and Cambridge, England-based firm delivering therapies that enable sufferers to reside on their very own phrases, launched with USD 80M in financing since its inception in 2019. Backers included RA Capital Management, Access Biotechnology, and Intermediate Capital Group (ICG).
Source link
